Non-viral Delivery Systems for Breast Cancer Gene Therapy
- PMID: 28595562
- DOI: 10.2174/1566523217666170606124131
Non-viral Delivery Systems for Breast Cancer Gene Therapy
Abstract
Introduction: The ever-evolving field of gene therapy promises several innovative treatments for cancer. Advances in genetic modification of tumor cells and micro environment have led to the development of more effective therapeutic strategies with fewer side effects.
Materials & methods: The development of effective delivery system challenges, remains. Non-viral vectors are interesting due to their bio-safety and their ability to transfer different types of nucleic acids. Examples of these techniques are the use of oligonucleoides, liposomes, nanoparticles, inorganic material, and engineered stem cells.
Conclusion: In this review, we focus on recent advances in the intracellular delivery of DNA and siRNA to the cancer cells with emphasis on breast cancer.
Keywords: APTAMER; Breast cancer; DNA; Gene therapy; Non-viral delivery system; RNA.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.Curr Gene Ther. 2017;17(2):154-169. doi: 10.2174/1566523217666170510155803. Curr Gene Ther. 2017. PMID: 28494740 Review.
-
Non-viral nucleic acid containing nanoparticles as cancer therapeutics.Expert Opin Drug Deliv. 2016 Oct;13(10):1475-87. doi: 10.1080/17425247.2016.1190707. Epub 2016 Jun 6. Expert Opin Drug Deliv. 2016. PMID: 27248202 Free PMC article. Review.
-
Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.Curr Gene Ther. 2017;17(2):89-104. doi: 10.2174/1566523217666170510163038. Curr Gene Ther. 2017. PMID: 28494737 Review.
-
Gene Delivery Particle Engineering Strategies for Shape-dependent Targeting of Cells and Tissues.Curr Gene Ther. 2017;17(2):80-88. doi: 10.2174/1566523217666170510161120. Curr Gene Ther. 2017. PMID: 28494739
-
Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.J Control Release. 2013 Dec 10;172(2):589-600. doi: 10.1016/j.jconrel.2013.04.010. Epub 2013 Apr 25. J Control Release. 2013. PMID: 23624358 Free PMC article. Review.
Cited by
-
Electrotransfer of siRNA to Silence Enhanced Green Fluorescent Protein in Tumor Mediated by a High Intensity Pulsed Electromagnetic Field.Vaccines (Basel). 2020 Jan 27;8(1):49. doi: 10.3390/vaccines8010049. Vaccines (Basel). 2020. PMID: 32012775 Free PMC article.
-
CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting.Pharm Res. 2023 Jan;40(1):77-105. doi: 10.1007/s11095-022-03433-5. Epub 2022 Nov 15. Pharm Res. 2023. PMID: 36380168 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
